Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis KRYS

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History KRYS

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth KRYS

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin KRYS

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income KRYS

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM KRYS

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio KRYS

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Krystal Biotech Inc KRYS

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself KRYS

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 32.24
Forward PE 29.41
Enterprise Value Revenue 15.01
Price Sales TTM 16.71
Enterprise Value EBITDA 34.00
Price Book MRQ 5.56

Krystal Biotech Inc Dividends: – Yield, History, Payment Schedule

KRYS
Current price
221.96 USD +6.16 USD (+2.85%)
Last closed 217.46 USD
ISIN US5011471027
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 6 236 206 592 USD
Yield for 12 month +23.48 %
1Y
3Y
5Y
10Y
15Y
KRYS
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+290 515 000 USD

Last Year

+50 699 000 USD

Current Quarter

+97 800 000 USD

Last Quarter

+96 042 000 USD

Current Year

+270 454 000 USD

Last Year

+47 605 000 USD

Current Quarter

+92 137 000 USD

Last Quarter

+88 877 000 USD
EBITDA 159 672 992 USD
Operating Margin TTM 42.31 %
Price to Earnings 32.24
Return On Assets TTM 8.91 %
PEG Ratio
Return On Equity TTM 19.66 %
Wall Street Target Price 223.00 USD
Revenue TTM 373 164 000 USD
Book Value 39.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 16.60 %
Dividend Yield
Gross Profit TTM 351 758 016 USD
Earnings per share 6.67 USD
Diluted Eps TTM 6.67 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 192.30 %
Profit Margin 53.30 %

Technical Indicators KRYS

For 52 Weeks

122.80 USD 221.84 USD
50 Day MA 192.21 USD
Shares Short Prior Month 2 882 886
200 Day MA 163.63 USD
Short Ratio 9.05
Shares Short 2 865 989
Short Percent 16.54 %